These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 6317468)
1. The development of vasopressin antagonists. Sawyer WH; Manning M Fed Proc; 1984 Jan; 43(1):87-90. PubMed ID: 6317468 [TBL] [Abstract][Full Text] [Related]
2. Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Jard S; Gaillard RC; Guillon G; Marie J; Schoenenberg P; Muller AF; Manning M; Sawyer WH Mol Pharmacol; 1986 Aug; 30(2):171-7. PubMed ID: 3016500 [TBL] [Abstract][Full Text] [Related]
3. The use of antagonists of vasopressin in studies of its physiological functions. Sawyer WH; Manning M Fed Proc; 1985 Jan; 44(1 Pt 1):78-80. PubMed ID: 2981734 [TBL] [Abstract][Full Text] [Related]
4. [The clinical and experimental pharmacology of vasopressin agonists and antagonists]. Rudichenko VM Eksp Klin Farmakol; 1994; 57(2):68-73. PubMed ID: 8205056 [No Abstract] [Full Text] [Related]
5. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents. Manning M; Stoev S; Chini B; Durroux T; Mouillac B; Guillon G Prog Brain Res; 2008; 170():473-512. PubMed ID: 18655903 [TBL] [Abstract][Full Text] [Related]
6. No requirements of cyclic conformation of antagonists in binding to vasopressin receptors. Manning M; Przybylski JP; Olma A; Klis WA; Kruszynski M; Wo NC; Pelton GH; Sawyer WH Nature; 1987 Oct 29-Nov 4; 329(6142):839-40. PubMed ID: 2959865 [TBL] [Abstract][Full Text] [Related]
7. [Vasopressin isoreceptors in the liver and kidney: relationship between hormone binding and biological response]. Jard S J Physiol (Paris); 1981; 77(4-5):621-8. PubMed ID: 6268774 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of action of vasopressin and vasopressin antagonists. Jard S Kidney Int Suppl; 1988 Oct; 26():S38-42. PubMed ID: 2974096 [No Abstract] [Full Text] [Related]
9. Pharmacology and clinical perspectives of vasopressin antagonists. László FA; László F; De Wied D Pharmacol Rev; 1991 Mar; 43(1):73-108. PubMed ID: 1852013 [No Abstract] [Full Text] [Related]
10. [Vasopressin antagonists]. de Groote P Arch Mal Coeur Vaiss; 2002 Feb; 95 Spec 4(5 Spec 4):59-61. PubMed ID: 11933560 [TBL] [Abstract][Full Text] [Related]
11. Antagonists of the antidiuretic activity of vasopressin. Kinter LB; Huffman WF; Stassen FL Am J Physiol; 1988 Feb; 254(2 Pt 2):F165-77. PubMed ID: 2964201 [TBL] [Abstract][Full Text] [Related]
13. [Effect of estrone treatment on the antidiuretic activity of vasopressin]. Dávid MA; Kovács K Endokrinologie; 1964; 46(5):217-23. PubMed ID: 5878219 [No Abstract] [Full Text] [Related]
15. Functional characterization of vasopressin V1 and V2 receptors in the rabbit renal cortical collecting duct. Yoshitomi K; Naruse M; Hanaoka K; Yamamura Y; Imai M; Kurokawa K Kidney Int Suppl; 1996 Jun; 55():S177-82. PubMed ID: 8743549 [TBL] [Abstract][Full Text] [Related]
16. The development of potent and specific vasopressin antagonists. Sawyer WH; Manning M Kidney Int Suppl; 1988 Oct; 26():S34-7. PubMed ID: 3059031 [No Abstract] [Full Text] [Related]